Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan G Pol

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Oncoimmunology|July 26, 2023
Formyl peptide receptor-1 (FPR1) represses intestinal oncogenesisJulie Le Naour, Léa Montégut, Yuhong Pan, et al.
Pharmacological Research|October 17, 2020
The abundance of the long intergenic non-coding RNA 01087 differentiates between luminal and triple-negative breast cancers and predicts patient outcomeFatima Domenica Elisa De Palma, Valentina Del Monaco, Jonathan G Pol, et al.
Autophagy|December 12, 2024
Lysosomal damage due to cholesterol accumulation triggers immunogenic cell deathKarla Alvarez-Valadez, Allan Sauvat, Julien Diharce, et al.
Cell Death Discovery|December 10, 2020
Autophagy-mediated metabolic effects of aspirinFrancesca Castoldi, Juliette Humeau, Isabelle Martins, et al.
Cell Death and Differentiation|January 20, 2025
Epigenetic regulation of HOXA2 expression affects tumor progression and predicts breast cancer patient survivalFatima Domenica Elisa De Palma, Jonathan G Pol, Vincent Carbonnier, et al.
Nature Communications|September 18, 2020
Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancerAitziber Buqué, Norma Bloy, Maria Perez-Lanzón, et al.
Nature Communications|August 1, 2020
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancerAitziber Buqué, Norma Bloy, Maria Perez-Lanzón, et al.
Nature Immunology|April 5, 2016
S6K-STING interaction regulates cytosolic DNA-mediated activation of the transcription factor IRF3Fuan Wang, Tommy Alain, Kristy J Szretter, et al.
Oncoimmunology|December 15, 2018
Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trialsJonathan G Pol, Sergio A Acuna, Beta Yadollahi, et al.
Cancer Discovery|October 13, 2020
A TLR3 Ligand Reestablishes Chemotherapeutic Responses in the Context of FPR1 DeficiencyJulie Le Naour, Peng Liu, Liwei Zhao, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Oncoimmunology|July 26, 2023
Formyl peptide receptor-1 (FPR1) represses intestinal oncogenesisJulie Le Naour, Léa Montégut, Yuhong Pan, et al.
Pharmacological Research|October 17, 2020
The abundance of the long intergenic non-coding RNA 01087 differentiates between luminal and triple-negative breast cancers and predicts patient outcomeFatima Domenica Elisa De Palma, Valentina Del Monaco, Jonathan G Pol, et al.
Autophagy|December 12, 2024
Lysosomal damage due to cholesterol accumulation triggers immunogenic cell deathKarla Alvarez-Valadez, Allan Sauvat, Julien Diharce, et al.
Cell Death Discovery|December 10, 2020
Autophagy-mediated metabolic effects of aspirinFrancesca Castoldi, Juliette Humeau, Isabelle Martins, et al.
Cell Death and Differentiation|January 20, 2025
Epigenetic regulation of HOXA2 expression affects tumor progression and predicts breast cancer patient survivalFatima Domenica Elisa De Palma, Jonathan G Pol, Vincent Carbonnier, et al.
Nature Communications|September 18, 2020
Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancerAitziber Buqué, Norma Bloy, Maria Perez-Lanzón, et al.
Nature Communications|August 1, 2020
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancerAitziber Buqué, Norma Bloy, Maria Perez-Lanzón, et al.
Nature Immunology|April 5, 2016
S6K-STING interaction regulates cytosolic DNA-mediated activation of the transcription factor IRF3Fuan Wang, Tommy Alain, Kristy J Szretter, et al.
Oncoimmunology|December 15, 2018
Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trialsJonathan G Pol, Sergio A Acuna, Beta Yadollahi, et al.
Cancer Discovery|October 13, 2020
A TLR3 Ligand Reestablishes Chemotherapeutic Responses in the Context of FPR1 DeficiencyJulie Le Naour, Peng Liu, Liwei Zhao, et al.
Pageof 6